Beacon Biosignals

Making brain function measurable and actionable at scale

Boston, United States · Founded 2019 · $213.0M raised

Headquarters
Boston
Employees
51–200
Founded
2019
Business Model
B2B
Website
beacon.bio
Total Funding
$213.0M
Last Round
$97.0M Series BApr 2026
Rounds
4

About

Beacon Biosignals is a neurotechnology company using AI-powered EEG analytics to accelerate drug development for neurological and psychiatric disorders. Its platform analyzes real-world brain data from clinical trials, helping biopharma companies measure treatment efficacy and identify biomarkers across epilepsy, sleep disorders, and other conditions.

Summary

Beacon Biosignals is an Artificial Intelligence company based in Boston, United States, founded in 2019. It has raised $213.0M in total across 4 rounds, most recently a $97.0M Series B round in Apr 2026. Investors include General Catalyst, Innoviva and Section 32.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries B ExtensionApr 2026
$97.0M

Sign up to see all 4 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Beacon Biosignals on Indexed.vc
<a href="https://indexed.vc/companies/beacon-biosignals"><img src="https://indexed.vc/api/badge/company/beacon-biosignals" alt="Beacon Biosignals on Indexed.vc" width="260" height="76" /></a>